So much for continuous disclosure.......

Today's announcment makes a complete mockery of continuous disclosure obligations.

The stock has had unusually strong support at 10c, 10.5c, 11c without any real reason.........

So today they announce exciting developments on BNC 210.

The Announcement about the failure of this compound to meet its primary trial endpoint for PTSD also carried the decision that there would be NO MORE WORK on BNC 210 other than the Agitation Trial.

Well obviously THAT was a lie!

I could smell a rat by the market support - and by observation it would not be unfair to suggest that some people obviously knew more than the rest of the muppets following this fleabag.

Take advantage of the spike as it surely will not last.

The idea of continuous disclosure does not apply at Bionomics and the Executive Chair needs a belt around the ears for this failure.

What a joke.